UA96602C2 - Способ получения инсулинотропных пептидов - Google Patents

Способ получения инсулинотропных пептидов

Info

Publication number
UA96602C2
UA96602C2 UAA200900414A UAA200900414A UA96602C2 UA 96602 C2 UA96602 C2 UA 96602C2 UA A200900414 A UAA200900414 A UA A200900414A UA A200900414 A UAA200900414 A UA A200900414A UA 96602 C2 UA96602 C2 UA 96602C2
Authority
UA
Ukraine
Prior art keywords
fragments
solid
solution phase
fragment
eases
Prior art date
Application number
UAA200900414A
Other languages
English (en)
Ukrainian (uk)
Inventor
Линь Чень
Ень-Гуй Хань
Кристофер Р. Робертс
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of UA96602C2 publication Critical patent/UA96602C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Изобретение относится к способу получения инсулинотропных пептидов, которые синтезируют с использованием подхода, основанного на применении твердо-фазового и жидкостно-фазового («гибридного») синтеза. Указанный подход предусматривает синтез трех разных пептидных промежуточных фрагментов с помощью твердо-фазовой химии с дальнейшим использованием жидкостно-фазовой химии для добавления аминокислотного продукта к одному из фрагментов. Потом осуществляют соединение фрагментов друг с другом с использованием твердой и жидкой фаз. Применение псевдопролина в одном из фрагментов облегчает твердо-фазовый синтез этого фрагмента и облегчает также следующее соединение этого фрагмента с другими фрагментами в жидкой фазе. Данное изобрете
UAA200900414A 2006-06-23 2007-06-19 Способ получения инсулинотропных пептидов UA96602C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23

Publications (1)

Publication Number Publication Date
UA96602C2 true UA96602C2 (ru) 2011-11-25

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900414A UA96602C2 (ru) 2006-06-23 2007-06-19 Способ получения инсулинотропных пептидов

Country Status (33)

Country Link
US (2) US20080004429A1 (ru)
EP (1) EP2035451B1 (ru)
JP (1) JP4537495B2 (ru)
KR (1) KR101087859B1 (ru)
CN (1) CN101563364B (ru)
AR (1) AR061604A1 (ru)
AT (1) ATE466881T1 (ru)
AU (1) AU2007263043B2 (ru)
BR (1) BRPI0713575A2 (ru)
CA (1) CA2654610C (ru)
CL (1) CL2007001835A1 (ru)
CR (1) CR10463A (ru)
CY (1) CY1110186T1 (ru)
DE (1) DE602007006310D1 (ru)
DK (1) DK2035451T3 (ru)
EC (1) ECSP088999A (ru)
ES (1) ES2341588T3 (ru)
HR (1) HRP20100302T1 (ru)
IL (1) IL195421A0 (ru)
MA (1) MA30530B1 (ru)
MX (1) MX2008015935A (ru)
MY (1) MY144608A (ru)
NO (1) NO20084863L (ru)
NZ (1) NZ573093A (ru)
PL (1) PL2035451T3 (ru)
PT (1) PT2035451E (ru)
RS (1) RS51281B (ru)
RU (1) RU2448978C2 (ru)
SI (1) SI2035451T1 (ru)
TW (1) TWI331155B (ru)
UA (1) UA96602C2 (ru)
WO (1) WO2007147816A1 (ru)
ZA (1) ZA200810072B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053315A1 (en) * 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CN101903400B (zh) * 2007-12-11 2013-12-18 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
US20100317057A1 (en) * 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
CN102414220A (zh) * 2009-05-01 2012-04-11 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
EP2788110B1 (en) * 2011-12-08 2018-10-17 Pentair Water Pool and Spa, Inc. Aquaculture system and method of operating a pump in such a system
WO2013098191A1 (en) * 2011-12-29 2013-07-04 Novo Nordisk A/S Dipeptide comprising a non-proteogenic amino acid
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
EP3704143B1 (en) * 2018-03-09 2023-10-18 Fresenius Kabi iPSUM S.r.l. Chemo-enzymatic synthesis of liraglutide, semaglutide and glp-1
CN111757891A (zh) 2018-03-09 2020-10-09 恩细贝普有限公司 索马鲁肽、利拉鲁肽和glp-1的化学-酶法合成
US11396533B2 (en) 2018-10-09 2022-07-26 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of GLP-1 analogues
TWI738260B (zh) 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
WO2020254479A1 (en) * 2019-06-18 2020-12-24 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of glucagon
EP3753946A1 (en) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Improved process for the preparation of high purity glucagon
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
AU5441096A (en) * 1995-04-14 1996-10-30 The Administrators Of The Tulane Eductional Fund Analogs of growth hormone-releasing factor
UA65549C2 (ru) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Применение аналогов и производных glp-1 для периферического введения для борьбы с ожирением
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
BR9915961A (pt) * 1998-12-07 2001-08-21 Sod Conseils Rech Applic Análogos de glp-1
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support

Also Published As

Publication number Publication date
EP2035451B1 (en) 2010-05-05
US20110213082A1 (en) 2011-09-01
IL195421A0 (en) 2011-08-01
ATE466881T1 (de) 2010-05-15
MA30530B1 (fr) 2009-06-01
CY1110186T1 (el) 2015-01-14
SI2035451T1 (sl) 2010-06-30
NZ573093A (en) 2012-01-12
MY144608A (en) 2011-10-14
RU2009101969A (ru) 2010-07-27
JP4537495B2 (ja) 2010-09-01
NO20084863L (no) 2009-01-22
TWI331155B (en) 2010-10-01
TW200811195A (en) 2008-03-01
WO2007147816A1 (en) 2007-12-27
US20080004429A1 (en) 2008-01-03
AR061604A1 (es) 2008-09-10
AU2007263043B2 (en) 2012-11-29
KR101087859B1 (ko) 2011-11-30
CN101563364B (zh) 2014-04-02
RS51281B (sr) 2010-12-31
CL2007001835A1 (es) 2008-03-14
DE602007006310D1 (ru) 2010-06-17
HRP20100302T1 (hr) 2010-06-30
CA2654610C (en) 2012-03-20
CA2654610A1 (en) 2007-12-27
MX2008015935A (es) 2009-01-13
KR20090023619A (ko) 2009-03-05
ZA200810072B (en) 2009-12-30
CN101563364A (zh) 2009-10-21
AU2007263043A1 (en) 2007-12-27
PT2035451E (pt) 2010-06-09
CR10463A (es) 2009-02-26
DK2035451T3 (da) 2010-06-07
ECSP088999A (es) 2009-01-30
ES2341588T3 (es) 2010-06-22
RU2448978C2 (ru) 2012-04-27
JP2009541257A (ja) 2009-11-26
PL2035451T3 (pl) 2010-08-31
BRPI0713575A2 (pt) 2013-02-13
EP2035451A1 (en) 2009-03-18

Similar Documents

Publication Publication Date Title
UA96602C2 (ru) Способ получения инсулинотропных пептидов
MX2010006044A (es) Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
GEP20146112B (en) Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and usage thereof
TR201816260T4 (tr) Wt1-antijen peptid konjugat aşı.
WO2009018126A3 (en) Collagen-related peptides and uses thereof
WO2006024275A3 (de) Erfindung betreffend glp-1 und exendin
NZ597554A (en) Selective glucagon-like-peptide-2 (glp-2) analogues
WO2003059951A8 (fr) Anticorps anti-igf-ir et leurs applications
NZ595825A (en) Antibody containing igg2 having amino acid mutation introduced therein
WO2007120834A3 (en) Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
Chen et al. Selective lysine modification of native peptides via aza-Michael addition
WO2007070672A3 (en) Non-natural amino acids and neurotensin analogues thereof
WO2008113970A3 (en) Peptides
TW200833371A (en) Process for solid formulations
WO2007100358A3 (en) Convergent synthesis of proteins by kinetically controlled ligation
IL184080A (en) Synthesis of peptide t-20 using peptide intermediate fragments
MX2009012085A (es) Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos.
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
DE602005016024D1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
KR20220093087A (ko) Mmp2 저해 작용을 갖는 폴리펩티드
GB0522295D0 (en) Peptides and uses thereof
WO2008029138A3 (en) Peptides and methods
TH107349A (th) การสังเคราะห์อินซูลิโนโทรพิค เปปไทด์
Liao et al. Selective Coupling at the α-Amino Group of Cysteine Using Transfer Active-ester-condensation Technology to Synthesize a Linear Octadecapeptide